Medline Inc.
For the period ended Sep 26, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 26, 2026 · Filed Nov 4, 2026
MDLN$40.91+0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income
MEDLINE INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
| Three months ended | Nine months ended | |||
|---|---|---|---|---|
| (in millions, except per share amounts) | September 26, 2026 | September 27, 2025 | September 26, 2026 | September 27, 2025 |
| Net sales | $7,856 | $7,115 | $22,893 | $20,645 |
| Cost of goods sold | 5,931 | 5,240 | 16,912 | 15,041 |
| Gross profit | 1,925 | 1,875 | 5,981 | 5,604 |
| Operating expense | ||||
| Selling, general and administrative expenses | 1,259 | 1,116 | 3,782 | 3,259 |
| Amortization of intangible assets | 176 | 177 | 529 | 528 |
| Other operating (income) expenses, net | (10) | 8 | 353 | 30 |
| Total operating expense | 1,425 | 1,301 | 4,664 | 3,817 |
| Operating income | 500 | 574 | 1,317 | 1,787 |
| Other expense | ||||
| Interest expense, net | (118) | (213) | (373) | (646) |
| Other loss, net | (1) | (6) | (42) | (6) |
| Foreign exchange gain (loss), net | 5 | (10) | 10 | (93) |
| Total other expense | (114) | (229) | (405) | (745) |
| Income before income taxes | 386 | 345 | 912 | 1,042 |
| Provision for income taxes | 68 | 23 | 216 | 65 |
| Net income | 318 | 322 | 696 | 977 |
| Net income attributable to noncontrolling interests | 123 | — | 312 | — |
| Net income attributable to Medline Inc. | $195 | $322 | $384 | $977 |
| Earnings per share attributable to Medline Inc. | ||||
| Basic | $0.23 | N/A | $0.46 | N/A |
| Diluted | $0.22 | N/A | $0.45 | N/A |
| Weighted-average number of Class A common stock outstanding | ||||
| Basic | 876 | N/A | 851 | N/A |
| Diluted | 1,316 | N/A | 1,317 | N/A |
| Other comprehensive income (loss), net of tax | ||||
| Net unrealized loss on derivative instruments | (10) | (20) | (22) | (70) |
| Currency translation adjustment | 13 | 10 | (26) | 111 |
| Total other comprehensive income (loss), net of tax | 3 | (10) | (48) | 41 |
| Total comprehensive income | 321 | 312 | 648 | 1,018 |
| Comprehensive income attributable to noncontrolling interests | 124 | — | 295 | — |
| Comprehensive income attributable to Medline Inc. | $197 | $312 | $353 | $1,018 |
See notes to unaudited condensed consolidated financial statements.
8
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.